Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-16 4:34 pm Sale | 2024-09-12 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 1,860,906 9.990% | -409,185 (-18.03%) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | 89bio, Inc. ETNB | OrbiMed Israel BioFund GP Limited Partnership | 17,877,653 9.990% | 5,299,832 (+42.14%) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | 89bio, Inc. ETNB | OrbiMed Israel BioFund GP Limited Partnership | 12,577,821 19.900% | 7,976,013 (+173.32%) | Filing History |
| 2024-03-11 7:19 pm Unchanged | 2024-03-11 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 16.000% | 0 (Unchanged) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | 89bio, Inc. ETNB | OrbiMed Israel BioFund GP Limited Partnership | 4,601,808 9.900% | 48,319 (+1.06%) | Filing History |
| 2023-11-15 4:35 pm Unchanged | 2023-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 18.300% | 0 (Unchanged) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | 89bio, Inc. ETNB | OrbiMed Israel BioFund GP Limited Partnership | 4,553,489 9.900% | 1,017,000 (+28.76%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | 89bio, Inc. ETNB | OrbiMed Israel BioFund GP Limited Partnership | 3,536,489 10.500% | 3,536,489 (New Position) | Filing History |
| 2023-01-05 4:31 pm Sale | 2023-01-03 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 19.700% | -49,869,729 (-95.65%) | Filing History |
| 2022-07-01 5:20 pm Sale | 2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% | -3,027,545 (-19.68%) | Filing History |
| 2021-06-28 5:24 pm Sale | 2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% | -17,118,837 (-52.67%) | Filing History |
| 2021-04-07 4:46 pm Unchanged | 2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% | 0 (Unchanged) | Filing History |
| 2021-03-26 4:06 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 52,139,820 24.300% | 52,139,820 (New Position) | Filing History |
| 2021-03-25 5:26 pm Unchanged | 2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% | 0 (Unchanged) | Filing History |
| 2021-01-05 4:38 pm Unchanged | 2020-12-22 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.500% | 0 (Unchanged) | Filing History |
| 2020-12-16 5:13 pm Purchase | 2020-12-15 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16.000% | 1,943,734 (+6.36%) | Filing History |
| 2020-12-04 5:12 pm Sale | 2020-12-02 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 5.100% | -103,200 (-58.35%) | Filing History |
| 2020-11-20 4:39 pm Unchanged | 2020-11-16 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 12.400% | 0 (Unchanged) | Filing History |
| 2020-10-13 9:20 pm Purchase | 2020-10-05 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 14.100% | 176,850 (New Position) | Filing History |
| 2020-08-18 4:35 pm Unchanged | 2020-08-14 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.400% | 0 (Unchanged) | Filing History |